Trials / Completed
CompletedNCT01287182
Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Omicron Pharmaceuticals · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is a trial of Ateronon in Patients with Coronary Disease to Evaluate its Effectiveness in Assessing the Risk Factors of Atherosclerosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ateronon | Ateronon daily for 3 months |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-02-01
- Last updated
- 2013-05-21
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT01287182. Inclusion in this directory is not an endorsement.